文献速递呼吸衰竭与机械通气心脑血管急症消化、代谢与肾脏急症

混合单光子发射计算机断层扫描联合计算机断层扫描在肺栓塞诊断中的经济价值

The Economic Value of Hybrid Single-photon Emission Computed Tomography With Computed Tomography Imaging in Pulmonary Embolism Diagnosis.
PubMed 文献 · Acad Emerg Med · 2017-08-14
一句话结论基于Excel模拟模型,疑诊肺栓塞急诊患者以SPECT/CT作为初始影像学检查,与CTPA、平面V/Q显像和V/Q SPECT相比,每位患者每月分别节省51.80、213.80、36.30美元。

该研究构建基于Excel的模拟模型,从支付方角度比较SPECT/CT与CTPA、平面V/Q显像、V/Q SPECT在急诊疑诊肺栓塞患者中的经济价值,临床终点与相应费用数据(2016年美元)来自对已发表文献的最佳证据回顾,研究按样本量加权合并。每1000例疑诊肺栓塞接受影像检查患者中,各模态年经济负担为SPECT/CT 320万美元、CTPA 380万美元、平面显像580万美元、SPECT 360万美元。转换为SPECT/CT技术后,每位患者每月费用节省为对比CTPA 51.80美元、对比平面显像213.80美元、对比SPECT 36.30美元,增量挽救生命数对比CTPA为6例、对比平面显像为3例。以SPECT/CT作为急性肺栓塞初始影像检查,预计每年可为支付方或健康计划节省「潜在可避免」的超额费用:对比CTPA 994777美元、对比平面显像2852014美元、对比SPECT 435038美元。

要点

  • 每1000例疑诊肺栓塞接受影像检查患者,年经济负担为SPECT/CT 320万美元、CTPA 380万美元、平面V/Q显像580万美元、V/Q SPECT 360万美元。
  • 转换为SPECT/CT后每位患者每月费用节省:对比CTPA 51.80美元、对比平面显像213.80美元、对比SPECT 36.30美元(2016年美元)。
  • 模型计算SPECT/CT增量挽救生命数对比CTPA为6例、对比平面显像为3例。
  • 以SPECT/CT作为急性肺栓塞初始影像检查,预计每年节省「潜在可避免」超额费用:对比CTPA 994777美元、对比平面显像2852014美元、对比SPECT 435038美元。
  • SPECT/CT似乎具有更优经济价值,主要归因于更高的敏感度与特异度以及较低的非诊断率。

适用人群与场景

  • 急诊环境下疑诊肺栓塞并接受影像学检查的患者(模型以每1000例此类患者为计算基础)。

研究设计与关键结果

  • 研究类型为基于Excel的模拟模型,从支付方角度比较SPECT/CT与CTPA、平面V/Q显像、V/Q SPECT;临床终点(诊断、治疗、并发症、死亡)及相应费用数据(2016年美元)来自对已发表文献的最佳证据回顾,研究合并后参数按样本量加权。
  • 每1000例疑诊肺栓塞接受影像检查患者的年经济负担:SPECT/CT 320万美元、CTPA 380万美元、平面V/Q显像580万美元、V/Q SPECT 360万美元。
  • 转换为SPECT/CT技术后每位患者每月费用节省:对比CTPA 51.80美元、对比平面V/Q显像213.80美元、对比V/Q SPECT 36.30美元。
  • 模型计算SPECT/CT增量挽救生命数:对比CTPA为6例、对比平面V/Q显像为3例。
  • 以SPECT/CT作为急性肺栓塞初始影像检查,预计每年节省「潜在可避免」超额费用:对比CTPA 994777美元、对比平面V/Q显像2852014美元、对比V/Q SPECT 435038美元。
  • 进行了单因素(±25%)敏感性分析和三种情景分析以评估结果的稳健性。

证据类型、等级与局限

  • 证据类型:基于已发表文献最佳证据回顾构建的Excel模拟模型(经济评价),非前瞻性临床研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,与目前可用的疑诊肺栓塞扫描技术相比,SPECT/CT似乎具有更优的经济价值,主要归因于更高的敏感度和特异度以及较低的非诊断率。
  • 作者认为,提高的诊断准确率使该模态因潜在可避免的并发症、误诊和漏诊而发生的费用比例最低。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: The objective was to quantify the potential economic value of single-photon emission computed tomography (SPECT) with computed tomography (CT; SPECT/CT) versus CT pulmonary angiography (CTPA), ventilation-perfusion (V/Q) planar scintigraphy, and V/Q SPECT imaging modalities for diagnosing suspected pulmonary embolism (PE) patients in an emergency setting.

METHODS: An Excel-based simulation model was developed to compare SPECT/CT versus the alternate scanning technologies from a payer's perspective. Clinical endpoints (diagnosis, treatment, complications, and mortality) and their corresponding cost data (2016 USD) were obtained by performing a best evidence review of the published literature. Studies were pooled and parameters were weighted by sample size. Outcomes measured included differences in 1) excess costs, 2) total costs, and 3) lives lost per annum between SPECT/CT and the other imaging modalities. One-way (±25%) sensitivity and three scenario analyses were performed to gauge the robustness of the results.

RESULTS: For every 1,000 suspected PE patients undergoing imaging, expected annual economic burden by modality was found to be 3.2 million (SPECT/CT), 3.8 million (CTPA), 5.8 million (planar), and 3.6 million (SPECT) USD, with a switch to SPECT/CT technology yielding per-patient-per-month cost savings of $51.80 (vs. CTPA), $213.80 (vs. planar), and $36.30 (vs. SPECT), respectively. The model calculated that the incremental number of lives saved with SPECT/CT was six (vs. CTPA) and three (vs. planar). Utilizing SPECT/CT as the initial imaging modality for workup of acute PE was also expected to save $994,777 (vs. CTPA), $2,852,014 (vs. planar), and $435,038 (vs. SPECT) in "potentially avoidable"' excess costs per annum for a payer or health plan.

CONCLUSION: Compared to the currently available scanning technologies for diagnosing suspected PE, SPECT/CT appears to confer superior economic value, primarily via improved sensitivity and specificity and low nondiagnostic rates. In turn, the improved diagnostic accuracy accords this modality the lowest ratio of expenses attributable to potentially avoidable complications, misdiagnosis, and underdiagnosis.

来源:Acad Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Toney LK, Kim RD, Palli SR, et al. The Economic Value of Hybrid Single-photon Emission Computed Tomography With Computed Tomography Imaging in Pulmonary Embolism Diagnosis. Acad Emerg Med. 2017. PMID: 28650562. doi:10.1111/acem.13247

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。